Abh Pennsylvania Childrens Services Inc
ABH PENNSYLVANIA CHILDRENS SERVICES CHANGES LIVES BY UNLOCKING AND NURTURING HUMAN POTENTIAL FOR PEOPLE WITH EMOTIONAL, BEHAVIORAL, OR COGNITIVE DIFFERENCES. AT ABH PENNSYLVANIA CHILDRENS SERVICES, WE INTEGRATE THE LATEST SCIENTIFIC AND MEDICAL ADVANCEMENTS WITH TIME-TESTED PHILOSOPHIES AND COMPASSIONATE FAMILY ENGAGEMENT TO PROVIDE PRACTICAL, EFFECTIVE, AND EFFICIENT CARE, MAKING A MEANINGFUL DIFFERENCE IN THE LIVES OF THOSE WE SERVE, AND THE WORLD AROUND THEM. WE HELP CHANGE LIVES FOR PEOPLE WITH AUTISM, INTELLECTUAL AND DEVELOPMENTAL DISABILITIES, SPECIALTY MENTAL HEALTH NEEDS, AND CHILD WELFARE CONCERNS, WHILE SUPPORTING THE GOOD SOCIAL AND EMOTIONAL HEALTH OF ALL PEOPLE.
ICO
873801572
Web
Sign in to see organisation website
Traffic
186932
From Social media
News about from their social media (Facebook and X).
Data about organisation
Interesting nearby
Interesting organisations close by to residence of Abh Pennsylvania Childrens Services Inc
More Interesting nearbySimilar traffic
Organisations with similar web traffic to Abh Pennsylvania Childrens Services Inc
Similar trafficJoin us and make a difference for the future!
Sign Up
Please fill in your information. Everything is free, we might contact you with updates (but cancel any time!)
Sign in with GoogleOr
Good News

Thrilled to hear about Ventyx Biosciences' positive Phase 2 study results for VTX3232! 🎉 This breakthrough could be a game-changer for patients dealing with obesity and cardiovascular issues. It's inspiring to see science and innovation pave the way for better health! #GoodNews #HealthForAll
Ventyx Stock Is Rallying Thursday: What's Driving The Surge? - Ventyx Biosciences (NASDAQ:VTYX)
Benzinga
Like Comment
Exciting news! 🌟 GemPharmatech is teaming up with MSK Cancer Center to fast-track the discovery of therapeutic antibodies! Together, they’re bringing hope to cancer research and making strides for better treatments. 💪 #CancerResearch #PositiveChange #EduoOrg
GemPharmatech collaborates with MSK Cancer Center to accelerate discovery of therapeutic antibodies
News-Medical.net
Like Comment